- Filed
- May 20, 2025
- Last modified
- Mar 9, 2026
- Petitioner
- Samsung Electronics Co., Ltd. et al.
- Inventor
- Shih-Yuan WANG et al
Patent 10468543
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Active provider: Google · gemini-2.5-flash
Proceedings on file (1)
All PTAB activity →AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.
Current assignee: W&Wsens Devices Inc.
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Based on the provided information and publicly available data, here is an analysis of the PTAB proceedings for U.S. Patent No. 10,468,543.
Proceedings Overview
There has been one inter partes review (IPR) filed against U.S. Patent No. 10,468,543. The a petition for IPR was discretionarily denied by the Patent Trial and Appeal Board (PTAB). This means the patent has not yet been reviewed on its merits in an AIA trial, leaving all claims intact and providing a neutral but not strengthened defensive position for a defendant.
IPR2025-00995 — [[[Samsung Electronics Co.](/litigations/by-defendant/Samsung%20Electronics%20Co.), Ltd.](/litigations/by-plaintiff/Samsung%20Electronics%20Co.%2C%20Ltd.) et al.](/litigations/by-plaintiff/Samsung%20Electronics%20Co.%2C%20Ltd.%20et%20al.) v. W&Wsens Devices, Inc.
- Type: Inter Partes Review
- Filed: 2025-05-20
- Status: Discretionary Denial. This means the PTAB declined to institute a trial, not on the merits of the invalidity arguments, but for other reasons, likely related to the parallel district court litigation.
- Judge panel: The institution decision was made under the Director Review process, where the USPTO Director has assumed the role of deciding whether to institute AIA trials. As such, a traditional three-judge panel was not assigned for the institution decision.
- Petition grounds: The petition likely asserted that claims of the '543 patent were unpatentable as obvious under 35 U.S.C. § 103, which is a common ground for IPR petitions. Specific claims and prior art combinations are not detailed in the available summary information, but would be found in the petition document itself.
- Institution decision: Institution was discretionarily denied on November 20, 2025. The PTAB's decision was likely influenced by the parallel district court litigation (W&Wsens Devices Inc. v. Samsung Electronics Co., Ltd., 2:24-cv-00854, E.D. Texas) and the a desire to avoid duplicative proceedings or a race to the courthouse.
- Final Written Decision: Not applicable, as the IPR was not instituted.
- Settlement / termination: There is no public record of a settlement in this specific IPR. The denial of institution terminated the PTAB proceeding.
- Appeal: Institution decisions are not appealable.
- Defensive value: The discretionary denial means the prior art and arguments presented by Samsung were never considered on their merits by the PTAB. A future defendant is not estopped from raising the same or different invalidity arguments in district court. However, the fact that the PTAB declined to institute may be viewed by a court as a minor, albeit not legally binding, indication of the petition's strength.
Strategic Summary
- Claims Status: All claims of U.S. Patent No. 10,468,543 remain valid and enforceable as they have not been substantively reviewed in an IPR.
- Estoppel Landscape: Because the IPR was not instituted, 35 U.S.C. § 315(e)(2) estoppel does not apply. This means that Samsung, its co-petitioners, and any real parties in interest are not barred from raising the same invalidity grounds in the ongoing district court case or in future proceedings. Any other potential defendant is also free to challenge the patent on any grounds.
- Pattern Signals: W&Wsens Devices Inc. has asserted a portfolio of related patents against Samsung in district court. Samsung has responded by filing multiple IPR petitions against these patents. The denial of this petition, along with others, appears to be part of a broader trend of the USPTO exercising discretion to deny institution, particularly when there is co-pending district court litigation.
Recommended Next Steps
For a defendant facing an assertion of U.S. Patent No. 10,468,543:
Review the IPR File Wrapper: Obtain the complete file history for IPR2025-00995 from the USPTO's Patent Trial and Appeal Board End-to-End (PTAB E2E) system. This will provide the full petition, including the specific prior art and arguments Samsung raised. While these arguments did not lead to a trial, they offer a starting point for your own invalidity analysis.
Analyze the Discretionary Denial: Carefully read the PTAB's decision for IPR2025-00995. Understanding the specific reasons for the discretionary denial is crucial. If the denial was based on factors unique to the Samsung case (e.g., timing, overlap with district court arguments), it may not preclude a future, well-crafted petition from a different party from being instituted.
Conduct Independent Prior Art Search: Do not solely rely on the art cited by Samsung. A comprehensive prior art search is essential to identify stronger or alternative invalidity grounds.
Monitor District Court Litigation: Closely follow the ongoing case W&Wsens Devices Inc. v. Samsung Electronics Co., Ltd., 2:24-cv-00854 in the Eastern District of Texas. The court's claim construction rulings and any validity determinations will be highly relevant. As of early 2026, a technical advisor has been appointed in that case, and claim construction proceedings are likely underway.
Consider Reexamination: As an alternative to an IPR, ex parte reexamination is another avenue to challenge the patent's validity at the USPTO. This can be a strategic option, particularly if new, strong prior art is discovered.
Generated 5/14/2026, 6:47:00 PM